Biofertalis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,852 | 23,684 | 88,594 | 207,964 | 710,694 | 624,885 | 810,528 | 561,465 |
| Profit before tax | 42 | - | - | - | - | - | 7,431 | 36,086 |
| Net profit | 39 | 3,225 | 40,773 | -4,026 | 15,904 | 4,188 | 6,178 | 36,086 |
| Equity | 17,430 | 20,655 | 61,428 | 57,402 | 73,306 | 77,493 | 83,671 | 119,757 |
| Liabilities | 1,886 | 25,051 | 60,383 | 207,206 | 507,866 | 438,899 | 491,764 | 475,333 |
| Non-current assets | 4,812 | 4,615 | 37,425 | 156,606 | 352,669 | 485,877 | 484,159 | 481,979 |
| Current assets | 14,504 | 41,091 | 84,168 | 140,154 | 254,006 | 198,429 | 228,760 | 230,856 |
| Total assets | 19,316 | 45,706 | 121,593 | 296,760 | 606,675 | 684,306 | 712,919 | 712,835 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 57,269 | 107,050 | 100,652 |
| Social insurance contributions | - | - | - | - | - | 37,942 | 49,072 | 40,273 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -81.6% | +1178.8% | +274.1% | +134.7% | +241.7% | -12.1% | +29.7% | -30.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.2% | 7.1% | 33.5% | -1.4% | 2.6% | 0.6% | 0.9% | 5.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.2% | 15.6% | 66.4% | -7.0% | 21.7% | 5.4% | 7.4% | 30.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.1% | 13.6% | 46.0% | -1.9% | 2.2% | 0.7% | 0.8% | 6.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.3% | - | - | - | - | - | 0.9% | 6.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 1.2 | 1.0 | 3.6 | 6.9 | 5.7 | 5.9 | 4.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,852 | 23,684 | 88,594 | 92,428 | 115,247 | 97,384 | 117,184 | 118,203 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biofertalis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-17 | 5133.87 |
| 2026-03-27 | 2026-03-27 | 3868.04 |
| 2026-03-17 | 2026-03-18 | 3868.04 |
| 2026-01-21 | 2026-02-16 | 0.88 |
| 2025-06-11 | 2025-06-12 | 0.01 |
| 2025-06-08 | 2025-06-09 | 0.01 |
| 2025-05-16 | 2025-06-04 | 0.01 |
| 2024-01-23 | 2024-02-14 | 0.88 |
| 2022-07-25 | 2022-08-11 | 2.41 |
| 2022-05-17 | 2022-05-25 | 805.42 |
| 2022-04-25 | 2022-05-10 | 1.22 |
| 2022-01-18 | 2022-01-18 | 2027.34 |
| 2021-12-16 | 2021-12-22 | 1390.47 |
| 2021-10-18 | 2021-10-19 | 192.63 |
Biofertalis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-29 | 2026-04-15 | 0.5 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biofertalis, UAB (code 303254067) is a Private Limited Liability Company engaged in materials recovery. In 2025, the company generated €561.5K in revenue and €36.1K in net profit, giving a profit margin of 6.4%. Revenue declined by 30.7% year on year and was 10.2% lower than two years earlier, after rising from €624.9K in 2023 to €810.5K in 2024 and then falling in 2025. Profitability improved materially in the latest year, with net profit increasing from €4.2K in 2023 and €6.2K in 2024 to €36.1K in 2025. The balance sheet remained broadly stable, with total assets of €712.8K, equity of €119.8K and liabilities of €475.3K at the end of 2025. Key indicators point to moderate leverage and efficient use of assets, including an equity ratio of 16.8%, debt-to-equity of 3.97, asset turnover of 0.79x, ROA of 5.1% and ROE of 30.1%. Revenue per employee was €140.4K, while profit per employee was €9.0K.